{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:08:48Z","timestamp":1780099728805,"version":"3.54.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s12026-021-09254-9","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T13:02:26Z","timestamp":1642251746000},"page":"240-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immunogenic and neutralization efficacy of recombinant perfringolysin O of Clostridium perfringens and its C-terminal receptor-binding domain in a murine model"],"prefix":"10.1007","volume":"70","author":[{"given":"Ankita","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6779-9425","authenticated-orcid":false,"given":"Devapriya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9761-7768","authenticated-orcid":false,"given":"Aparna","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"key":"9254_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/vr.167.1.12","volume":"167","author":"M Lebrun","year":"2010","unstructured":"Lebrun M, Mainil JG, Linden A. Cattle enterotoxaemia and Clostridium perfringens: description, diagnosis, and prophylaxis. Vet Rec. 2010;167:13\u201322. https:\/\/doi.org\/10.1136\/vr.167.1.12.","journal-title":"Vet Rec"},{"key":"9254_CR2","doi-asserted-by":"publisher","first-page":"106739","DOI":"10.1016\/j.foodcont.2019.106739","volume":"106","author":"M Li","year":"2019","unstructured":"Li M, Huang L, Zhu Y, Wei Q. Growth of Clostridium perfringens in roasted chicken and braised beef during cooling\u2013one-step dynamic analysis and modeling. Food Control. 2019;106:106739. https:\/\/doi.org\/10.1016\/j.foodcont.2019.106739.","journal-title":"Food Control"},{"key":"9254_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00248-006-9080-6","volume":"52","author":"WA Miller","year":"2006","unstructured":"Miller WA, Miller MA, Gardner IA, Atwill ER, Byrne BA, Jang S, Harris M, Ames J, Jessup D, Paradies D, Worcester K. Salmonella spp., Vibrio spp., Clostridium perfringens, and Plesiomonas shigelloides in marine and freshwater invertebrates from coastal California ecosystems. Microb Ecol. 2006;52:198\u2013206. https:\/\/doi.org\/10.1007\/s00248-006-9080-6.","journal-title":"Microb Ecol"},{"key":"9254_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.envpol.2003.09.004","volume":"127","author":"KA Hughes","year":"2004","unstructured":"Hughes KA, Thompson A. Distribution of sewage pollution around a maritime Antarctic research station indicated by faecal coliforms, Clostridium perfringens, and faecal sterol markers. Environ Pollut. 2004;127:315\u201321. https:\/\/doi.org\/10.1016\/j.envpol.2003.09.004.","journal-title":"Environ Pollut"},{"key":"9254_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2217\/fmb.13.168","volume":"9","author":"FA Uzal","year":"2014","unstructured":"Uzal FA, Freedman JC, Shrestha A, Theoret JR, Garcia J, Awad MM, Adams V, Moore RJ, Rood JI, McClane BA. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. 2014;9:361\u201377. https:\/\/doi.org\/10.2217\/fmb.13.168.","journal-title":"Future Microbiol"},{"key":"9254_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1071\/MA15039","volume":"36","author":"SA Revitt-Mills","year":"2015","unstructured":"Revitt-Mills SA, Rood JI, Adams V. Clostridium perfringens extracellular toxins and enzymes: 20 and counting. Microbiol Aust. 2015;36:114\u20137. https:\/\/doi.org\/10.1071\/MA15039.","journal-title":"Microbiol Aust"},{"key":"9254_CR7","first-page":"24","volume":"2","author":"FA Uzal","year":"2010","unstructured":"Uzal FA, Vidal JE, McClane BA, Gurjar AA. Clostridium perfringens toxins involved in mammalian veterinary diseases. Open Toxicol J. 2010;2:24.","journal-title":"Open Toxicol J"},{"key":"9254_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0966-842X(98)01430-9","volume":"7","author":"L Petit","year":"1999","unstructured":"Petit L, Gibert M, Popoff MR. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 1999;7:104\u201310. https:\/\/doi.org\/10.1016\/S0966-842X(98)01430-9.","journal-title":"Trends Microbiol"},{"key":"9254_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1128\/CMR.9.2.216-234.1996","volume":"9","author":"JG Songer","year":"1996","unstructured":"Songer JG. Clostridial enteric diseases of domestic animals. Clin Microbiol Rev. 1996;9:216\u201334. https:\/\/doi.org\/10.1128\/CMR.9.2.216-234.1996.","journal-title":"Clin Microbiol Rev"},{"key":"9254_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.anaerobe.2018.04.011","volume":"53","author":"JI Rood","year":"2018","unstructured":"Rood JI, Adams V, Lacey J, Lyras D, McClane BA, Melville SB, Moore RJ, Popoff MR, Sarker MR, Songer JG, Uzal FA, Van Immerseel F. Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe. 2018;53:5\u201310. https:\/\/doi.org\/10.1016\/j.anaerobe.2018.04.011.","journal-title":"Anaerobe"},{"key":"9254_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41426-018-0144-8","volume":"7","author":"R Kiu","year":"2018","unstructured":"Kiu R, Hall LJ. An update on the human and animal enteric pathogen Clostridium perfringens. Emerg Microbes Infect. 2018;7:1\u201315. https:\/\/doi.org\/10.1038\/s41426-018-0144-8.","journal-title":"Emerg Microbes Infect"},{"key":"9254_CR12","doi-asserted-by":"publisher","first-page":"7904","DOI":"10.1128\/IAI.69.12.7904-7910.2001","volume":"69","author":"MM Awad","year":"2001","unstructured":"Awad MM, Ellemor DM, Boyd RL, Emmins JJ, Rood JI. Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene. Infect Immun. 2001;69:7904\u201310. https:\/\/doi.org\/10.1128\/IAI.69.12.7904-7910.2001.","journal-title":"Infect Immun"},{"key":"9254_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1297-9716-44-45","volume":"44","author":"S Verherstraeten","year":"2013","unstructured":"Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Vermeulen K, Schauvliege S, Haesebrouck F, Ducatelle R, Deprez P, Van Immerseel F. The synergistic necrohemorrhagic action of Clostridium perfringens perfringolysin O and alpha toxin in the bovine intestine and against bovine endothelial cells. Vet Res. 2013;44:45. https:\/\/doi.org\/10.1186\/1297-9716-44-45.","journal-title":"Vet Res"},{"key":"9254_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.vetmic.2007.09.013","volume":"127","author":"ME Fernandez-Miyakawa","year":"2008","unstructured":"Fernandez-Miyakawa ME, Jost BH, Billington SJ, Uzal FA. Lethal effects of Clostridium perfringens epsilon toxin are potentiated by alpha and perfringolysin-O toxins in a mouse model. Vet Microbiol. 2008;127:379\u201385. https:\/\/doi.org\/10.1016\/j.vetmic.2007.09.013.","journal-title":"Vet Microbiol"},{"key":"9254_CR15","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1136\/vr.167.1.12","volume":"7","author":"S Verherstraeten","year":"2015","unstructured":"Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Haesebrouck F, Ducatelle R, Deprez P, Wade KR, Tweten R, Van Immerseel F. Perfringolysin O: The underrated Clostridium perfringens toxin? Toxins. 2015;7:1702\u201321. https:\/\/doi.org\/10.1136\/vr.167.1.12.","journal-title":"Toxins"},{"key":"9254_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/vr.b4869","volume":"167","author":"A Muylaert","year":"2010","unstructured":"Muylaert A, Lebrun M, Duprez JN, Labrozzo S, Theys H, Taminiau B, Mainil J. Enterotoxaemia-like syndrome and Clostridium perfringens in veal calves. Vet Res. 2010;167:64\u20135. https:\/\/doi.org\/10.1136\/vr.b4869.","journal-title":"Vet Res"},{"key":"9254_CR17","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1128\/CVI.00013-10","volume":"17","author":"D Chandran","year":"2010","unstructured":"Chandran D, Naidu SS, Sugumar P, Rani GS, Vijayan SP, Mathur D, Garg LC, Srinivasan VA. Development of a recombinant epsilon toxoid vaccine against enterotoxemia and its use as a combination vaccine with live attenuated sheep pox virus against enterotoxemia and sheep pox. Clin Vaccine Immunol. 2010;17:1013\u20136 (http:\/\/hdl.handle.net\/123456789\/236).","journal-title":"Clin Vaccine Immunol"},{"key":"9254_CR18","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1016\/j.vaccine.2010.07.046","volume":"28","author":"FC Lobato","year":"2010","unstructured":"Lobato FC, Lima CG, Assis RA, Pires PS, Silva RO, Salvarani FM, Carmo AO, Contigli C, Kalapothakis E. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants. Vaccine. 2010;28:6125\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.046.","journal-title":"Vaccine"},{"key":"9254_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12917-016-0730-8","volume":"12","author":"E Goossens","year":"2016","unstructured":"Goossens E, Verherstraeten S, Valgaeren BR, Pardon B, Timbermont L, Schauvliege S, Rodrigo-Mochol\u00ed D, Haesebrouck F, Ducatelle R, Deprez PR, Van Immerseel F. Toxin- neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis. BMC Vet Res. 2016;12:101\u2013101. https:\/\/doi.org\/10.1186\/s12917-016-0730-8.","journal-title":"BMC Vet Res"},{"key":"9254_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-016-0336-y","volume":"47","author":"E Goossens","year":"2016","unstructured":"Goossens E, Verherstraeten S, Valgaeren BR, PardonB Timbermont L, Schauvliege S, Rodrigo-Mochol\u00ed D, Haesebrouck F, Ducatelle R, Deprez PR, Van Immerseel F. The C- terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis. Vet Res. 2016;47:1\u20139. https:\/\/doi.org\/10.1186\/s13567-016-0336-y.","journal-title":"Vet Res"},{"key":"9254_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.anaerobe.2012.01.004","volume":"18","author":"A Milach","year":"2012","unstructured":"Milach A, de los Santos JRG, Turnes CG, Moreira \u00c2N, de Assis RA, Salvarani FM, Lobato FCF, Concei\u00e7\u00e3o FR. Production and characterization of Clostridium perfringens recombinant \u03b2 toxoid. Anaerobe. 2012;18:363\u20135. https:\/\/doi.org\/10.1016\/j.anaerobe.2012.01.004.","journal-title":"Anaerobe"},{"key":"9254_CR22","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1016\/j.vaccine.2013.06.094","volume":"31","author":"FM Salvarani","year":"2013","unstructured":"Salvarani FM, Conceic\u00e3o FR, Cunha CE, Moreira GM, Pires PS, Silva RO, Alves GG, Lobato FC. Vaccination with recombinant Clostridium perfringens toxoids \u03b1 and \u03b2 promotes elevated antepartum and passive humoral immunity in swine. Vaccine. 2013;31:4152\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.094.","journal-title":"Vaccine"},{"key":"9254_CR23","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1016\/j.vaccine.2013.04.061","volume":"31","author":"RP Langroudi","year":"2013","unstructured":"Langroudi RP, Shamsara M, Aghaiypour K. Expression of Clostridium perfringens epsilon-beta fusion toxin gene in E. coli and its immunologic studies in mouse. Vaccine. 2013;31:3295\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2013.04.061.","journal-title":"Vaccine"},{"key":"9254_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep22816","volume":"6","author":"GMSG Moreira","year":"2016","unstructured":"Moreira GMSG, Salvarani FM, Da Cunha CEP, Mendon\u00e7a M, Moreira \u00c2N, Gon\u00e7alves LA, Pires PS, Lobato FCF, Concei\u00e7\u00e3o FR. Immunogenicity of a trivalent recombinant vaccine against Clostridium perfringens alpha, beta, and epsilon toxins in farm ruminants. Sci Rep. 2016;6:1\u20139. https:\/\/doi.org\/10.1038\/srep22816.","journal-title":"Sci Rep"},{"key":"9254_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(00)80251-2","volume":"89","author":"J Rossjohn","year":"1997","unstructured":"Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell. 1997;89:685\u201392. https:\/\/doi.org\/10.1016\/S0092-8674(00)80251-2.","journal-title":"Cell"},{"key":"9254_CR26","doi-asserted-by":"publisher","first-page":"22629","DOI":"10.1074\/jbc.M703207200","volume":"282","author":"AP Heuck","year":"2007","unstructured":"Heuck AP, Savva CG, Holzenburg A, Johnson Johnson AE. Conformational changes that affect oligomerization and initiate pore formation are triggered throughout perfringolysin O upon binding to cholesterol. J Biol Chem. 2007;282:22629\u201337. https:\/\/doi.org\/10.1074\/jbc.M703207200.","journal-title":"J Biol Chem"},{"key":"9254_CR27","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1073\/pnas.0911581107","volume":"107","author":"AJ Farrand","year":"2010","unstructured":"Farrand AJ, LaChapelle S, Hotze EM, Johnson AE, Tweten RK. Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc Natl Acad Sci U S A. 2010;107:4341\u20136. https:\/\/doi.org\/10.1073\/pnas.0911581107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9254_CR28","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1046\/j.1432-1033.2002.03338.x","volume":"269","author":"Y Shimada","year":"2002","unstructured":"Shimada Y, Maruya M, Iwashita S, Ohno-Iwashita Y. The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains. Eur J Biochem. 2002;269:6195\u2013203. https:\/\/doi.org\/10.1046\/j.1432-1033.2002.03338.x.","journal-title":"Eur J Biochem"},{"key":"9254_CR29","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s12026-016-8807-9","volume":"64","author":"SK Yadav","year":"2016","unstructured":"Yadav SK, Meena JK, Sharma M, Dixit A. Recombinant outer membrane protein C of Aeromonas hydrophila elicits mixed immune response and generates agglutinating antibodies. Immunol Res. 2016;64:1087\u201399. https:\/\/doi.org\/10.1007\/s12026-016-8807-9.","journal-title":"Immunol Res"},{"key":"9254_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00253-019-10204-7","volume":"104","author":"S Karan","year":"2020","unstructured":"Karan S, Mohapatra A, Sahoo PK, Garg LC, Dixit A. Structural-functional characterization of recombinant apolipoprotein A-I from Labeo rohita demonstrates heat-resistant antimicrobial activity. Appl Microbiol Biotechnol. 2020;104:145\u201359. https:\/\/doi.org\/10.1007\/s00253-019-10204-7.","journal-title":"Appl Microbiol Biotechnol"},{"key":"9254_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12026-017-8953-8","volume":"66","author":"M Sharma","year":"2018","unstructured":"Sharma M, Dash P, Sahoo PK, Dixit A. Th2-biased immune response and agglutinating antibodies generation by a chimeric protein comprising OmpC epitope (323\u2013336) of Aeromonas hydrophila and LTB. Immunol Res. 2018;66:187\u201399. https:\/\/doi.org\/10.1007\/s12026-017-8953-8.","journal-title":"Immunol Res"},{"key":"9254_CR32","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1007\/s00253-015-6398-3","volume":"99","author":"M Sharma","year":"2015","unstructured":"Sharma M, Dixit A. Identification and immunogenic potential of B cell epitopes of outer membrane protein OmpF of Aeromonas hydrophila in translational fusion with a carrier protein. Appl Microbiol Biotechnol. 2015;99:6277\u201391. https:\/\/doi.org\/10.1007\/s00253-015-6398-3.","journal-title":"Appl Microbiol Biotechnol"},{"key":"9254_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","volume":"221","author":"A Frey","year":"1998","unstructured":"Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods. 1998;221:35\u201341. https:\/\/doi.org\/10.1016\/S0022-1759(98)00170-7.","journal-title":"J Immunol Methods"},{"key":"9254_CR34","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1128\/iai.56.12.3228-3234.1988","volume":"56","author":"RK Tweten","year":"1988","unstructured":"Tweten RK. Cloning and expression in Escherichia coli of the perfringolysin O (theta-toxin) gene from Clostridium perfringens and characterization of the gene product. Infect Immun. 1988;56:3228\u201334.","journal-title":"Infect Immun"},{"key":"9254_CR35","doi-asserted-by":"publisher","first-page":"H786","DOI":"10.1152\/ajpheart.00349.2008","volume":"295","author":"MS Hanson","year":"2008","unstructured":"Hanson MS, Stephenson AH, Bowles EA, Sridharan M, Adderley S, Sprague RS. Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP. Am J Physiol Heart Circ Physiol. 2008;295:H786\u201393. https:\/\/doi.org\/10.1152\/ajpheart.00349.2008.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9254_CR36","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3791\/1488","volume":"35","author":"A Ray","year":"2010","unstructured":"Ray A, Dittel BN. Isolation of mouse peritoneal cavity cells. J Vis Exp. 2010;35:1488. https:\/\/doi.org\/10.3791\/1488.","journal-title":"J Vis Exp"},{"key":"9254_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tvjl.2016.09.008","volume":"217","author":"S Verherstraeten","year":"2016","unstructured":"Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Haesebrouck F, Ducatelle R, Deprez P, Van Immerseel F. Non-toxic perfringolysin O and \u03b1-toxin derivatives as potential vaccine candidates against bovine necrohaemorrhagic enteritis. Vet J. 2016;217:89\u201394. https:\/\/doi.org\/10.1016\/j.tvjl.2016.09.008.","journal-title":"Vet J"},{"key":"9254_CR38","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/0264-410X(93)90051-X","volume":"11","author":"ED Williamson","year":"1993","unstructured":"Williamson ED, Titball RW. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine. 1993;11:1253\u20138. https:\/\/doi.org\/10.1016\/0264-410X(93)90051-X.","journal-title":"Vaccine"},{"key":"9254_CR39","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1086\/422691","volume":"190","author":"DL Stevens","year":"2004","unstructured":"Stevens DL, Titball RW, Jepson M, Bayer CR, Hayes-Schroer SM, Bryant AE. Immunization with the C-domain of \u03b1-toxin prevents lethal infection, localizes tissue injury, and promotes host response to challenge with Clostridium perfringens. J Infect Dis. 2004;190:767\u201373. https:\/\/doi.org\/10.1086\/422691.","journal-title":"J Infect Dis"},{"key":"9254_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/1348-0421.12198","volume":"58","author":"Z Jiang","year":"2014","unstructured":"Jiang Z, De Y, Chang J, Wang F, Yu L. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids. Microbiol Immunol. 2014;58:621\u20137. https:\/\/doi.org\/10.1111\/1348-0421.12198.","journal-title":"Microbiol Immunol"},{"key":"9254_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.sbi.2012.04.008","volume":"22","author":"MA Dunstone","year":"2012","unstructured":"Dunstone MA, Tweten RK. Packing a punch: the mechanism of pore formation by cholesterol dependent cytolysins and membrane attack complex\/perforin-like proteins. Curr Opin Struct Biol. 2012;22:342\u20139. https:\/\/doi.org\/10.1016\/j.sbi.2012.04.008.","journal-title":"Curr Opin Struct Biol"},{"key":"9254_CR42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0005-2736(00)00360-6","volume":"1510","author":"S Weis","year":"2001","unstructured":"Weis S, Palmer M. Streptolysin O: the C-terminal, tryptophan-rich domain carries functional sites for both membrane binding and self-interaction but not for stable oligomerization. Biochim Biophys Acta. 2001;1510:292\u20139. https:\/\/doi.org\/10.1016\/S0005-2736(00)00360-6.","journal-title":"Biochim Biophys Acta"},{"key":"9254_CR43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1046\/j.1440-1711.1999.00829.x","volume":"77","author":"C Cheers","year":"1999","unstructured":"Cheers C, Janas M, Ramsay A, Ramshaw I. Use of recombinant viruses to deliver cytokines influencing the course of experimental bacterial infection. Immunol Cell Biol. 1999;77:324\u201330. https:\/\/doi.org\/10.1046\/j.1440-1711.1999.00829.x.","journal-title":"Immunol Cell Biol"},{"key":"9254_CR44","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s11033-014-3033-9","volume":"41","author":"SK Yadav","year":"2014","unstructured":"Yadav SK, Sahoo PK, Dixit A. Characterization of immune response elicited by the recombinant outer membrane protein OmpF of Aeromonas hydrophila, a potential vaccine candidate in murine model. Mol Biol Rep. 2014;41:1837\u201348. https:\/\/doi.org\/10.1007\/s11033-014-3033-9.","journal-title":"Mol Biol Rep"},{"key":"9254_CR45","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.1128\/IAI.72.9.5204-5215.2004","volume":"72","author":"DK O'Brien","year":"2004","unstructured":"O\u2019Brien DK, Melville SB. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect Immun. 2004;72:5204\u201315. https:\/\/doi.org\/10.1128\/IAI.72.9.5204-5215.2004.","journal-title":"Infect Immun"},{"key":"9254_CR46","doi-asserted-by":"crossref","unstructured":"Virella G, Tsokos GC. The pathogenic role of antigen-antibody complexes. In Medical  Immunology. 7th ed.  Milton: CRC Press LLC; 2019.","DOI":"10.1201\/9780429278990-23"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-021-09254-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-021-09254-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-021-09254-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:23:26Z","timestamp":1744154606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-021-09254-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["9254"],"URL":"https:\/\/doi.org\/10.1007\/s12026-021-09254-9","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"10 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Animal Ethics Committee of the university approved the use of animals for the immunization study (project code IAEC # 03\/2019). All procedures were performed as per the guidelines and recommendations of the committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}